2565-005X

S2565-005X2025000400005

10.24875/j.gamo.25000092

México

00 12 2025

24 4 159 170

2021 32 12 12

1475-95

2018 2 4 4

pky062

2016 46 7 7

821-6

2017 34

122-30

2014 50 2 2

277-89

2017 377 6 6

523-33

2018 379 8 8

753-63

2019 380 20 20

1929-40

2023 388 22 22

2058-70

2020 396 10265 10265

1817-28

2020 3 10 10

2018 19 7 7

904-15

2016 375 20 20

1925-36

2016 375 18 18

1738-48

2017 35 32 32

3638-46

2019 5

2022 386 10 10

942-50

2024 42 23 23

2812-21

2016 17 4 4

425-39

2017 35 25 25

2875-84

2020 382 6 6

514-24

2018 36 24 24

2465-72

2018 36 16 16

1556-63

2019 30 4 4

558-66

2014 25 12 12

2357-62

2010 70 24 24

S1-6

2017 23 17 17

5218-24

2022 387 1 1

9-20

2022 40 29 29

3365-76

2020 21 4 4

519-30

2021 32 10 10

1245-55

2024 42 16 16

1007

2011 29 3 3

264-71

2023 401 10371 10371

105-17

2017 35 26 26

3030-38

2024 26 7 7

1539-48

2012 367 19 19

1783-91

2006 355 26 26

2733-43

2010 28 7 7

1124-30

2009 27 12 12

1999-2006

2024 76

103756

2024

2018 36 28 28

2826-35

2021 39 1 1

79-89

2022 387 3 3

217-26

2020 31 12 12

1623-49

2018 24 5 5

628-37

2022 45 7 7

279-85

2007 357 26 26

2666-76

2010 28 20 20

3239-47

2011 29 10 10

1252-60

2011 377 9769 9769

914-23

2008 26 24 24

3950-7

2006 24 27 27

4384-90

2009 27 11 11

1753-60

2006 24 18 18

570

2023 11 4 4

2003 97 12 12

2972-7

2018 7 3 3

2024 20 10 10

1348-59

2021 32 11 11

1332-47

2022 40 5 5

492-516

2024 72 3 3

520-7

2024 196

110288

2024 20 2 2

765-83

2023 8 5 5

101624

2020 26 20 20

5310-9

2024 30 8 8

oyae274

2024 30 12 12

3717-27

2024 26 10 10

1781-804

Surveillance, Epidemiology, and End Results Program

2015 1

528534

2015 2 2 2

159-70

2014 23 1 1

26-32

2017 31

46-50

2013 39 12 12

1377-83

2024 103 25 25

2022 40 16 16

1007

2010 17 9 9

2419-26

2023 21 4 4

242-9

2012 19 3 3

218-37

2017 17 4 4

256-65

1994 58 6 6

1599-602

2010 5 6 6

S130-1

2012 18 1 1

52-7

2013 9 2 2

181-6

Early surgery or standard palliative therapy in treating patients with stage IV breast cancer U. S. [Internet]. National Library of Medicine, Clinical Trials.gov;November 2010

2024 15 3 3

284-9

2024 22 1 1

300

2024 129

102784

2002 132 4 4

620-7

2007 14 8 8

2187-94

2006 24 18 18

2743-9

2008 15 12 12

3384-95

2009 35 11 11

1146-51

2012 84 1 1

39-45

2021 58

173-81

2020 20 1 1

392

2021 21 3 3

170-80

100

2021 233 6 6

742-751.e5

101

2015 16 13 13

1380-8

102

2019 269 6 6

1163-9

103

2020 38 18 18

LBA2

104

2021 28 9 9

5048-57

105

2021 12 2 2

421-7

106

2021 59

124-34

107

2022 223 1 1

81-93

108

2020 15 4 4

392-9

109

2019 45

104-12

110

2022 2022

5049445

111

2022 21

15330338221089937

112

2020 27 4 4

1025-33

113

2024 29 1 1

1-7

114

2020 27 4 4

1025-33

115

2023 13

1083297

116

2024 28 1 1

3-14

117

2024 14 5 5

377-97

118

2024 7 5 5

119

2025 79

103839

120

2025 205

110717

121

2024 28 1 1

111-8

122

2024 7 2 2

123

2024 28 1 1

75-82

124

2023 182

107284

125

2023 22

15330338231164537

126

2023 33 2 2

139-47

127

2024 27 4 4

223-34